Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00158015 · ClinicalTrials.gov registry record

Prospective Minnesota Study of ECHO Tissue Doppler Imaging in Cardiac Resynchronization Therapy

A clinical trial, sponsored by Hennepin Healthcare Research Institute.

Completed
Registry status
70
Enrollment target

NCT00158015: Completed study, sponsored by Hennepin Healthcare Research Institute.

NCT00158015 is a clinical trial that has completed, run by Hennepin Healthcare Research Institute. The registered enrollment target is 70 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00158015 has completed, sponsored by Hennepin Healthcare Research Institute.

COMPLETED
Registry status
70 participants
Enrollment target

Study Summary

The purpose of this study is to assess whether tissue doppler imaging is useful in predicting which patients will respond most to Cardiac Resynchronization therapy ( a type of pacemaker)

Trial Details

FieldValue
Enrollment Target 70 participants
Start Date 2004-10
Est. Completion 2007-09

What the finished NCT00158015 record still lists

NCT00158015 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 70 participants, a relatively small participant target.

The record links to 0 conditions, and to 0 interventions.

NCT00158015 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT00158015 about?

NCT00158015 is a clinical study titled "Prospective Minnesota Study of ECHO Tissue Doppler Imaging in Cardiac Resynchronization Therapy". The purpose of this study is to assess whether tissue doppler imaging is useful in predicting which patients will respond most to Cardiac Resynchronization therapy ( a type of pacemaker)

What is the current status of trial NCT00158015?

This trial is currently completed. The enrollment target is 70 participants. The study started on 2004-10. Estimated completion is 2007-09.

Who is sponsoring clinical trial NCT00158015?

This trial is sponsored by Hennepin Healthcare Research Institute, which has 63 total clinical trials registered on ClinicalTrials.gov.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00969111 · 70 participants · NA

    Postoperative or Salvage Radiotherapy (RT) for Node Negative Prostate Cancer Following Radical Prostatectomy

  • NCT01712620 · 70 participants · Phase 2

    Spironolactone for Pulmonary Arterial Hypertension

  • NCT02143830 · 70 participants · Phase 2

    HSCT for Patients With Fanconi Anemia Using Risk-Adjusted Chemotherapy

  • NCT02601339 · 70 participants

    NIRS Monitoring in Premature Infants

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00158015, the US trial registry maintained by the National Library of Medicine. NCT00158015 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.